Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03581994 · ClinicalTrials.gov registry record · NA
DDI Effectiveness and Clinical Awareness
A NA study, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT03581994 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 330 participants.
The verdict
NCT03581994, a NA study, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
The DECART study will determine if primary care physicians, including internists and family physicians, are able to identify and address drug-drug interactions among simulated patients and whether those physicians, when given access to Aegis Drug-Drug Interaction test results, improve patient management, take steps to reduce DDI risk, and optimize unnecessary resource utilization.
Interventions
- DIAGNOSTIC_TEST DDI Test Report
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2018-05-02 |
| Est. Completion | 2018-08-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03581994
The ClinicalTrials.gov registry entry for NCT03581994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qure Healthcare, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DDI Test Report is the first listed.
NCT03581994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03581994 about?
NCT03581994 is a clinical study titled "DDI Effectiveness and Clinical Awareness". The DECART study will determine if primary care physicians, including internists and family physicians, are able to identify and address drug-drug interactions among simulated patients and whether those physicians, when given access to Aegis Drug-Drug Interaction test results, improve patient manage...
What is the current status of trial NCT03581994?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2018-05-02. Estimated completion is 2018-08-28.
What interventions are being tested in trial NCT03581994?
The interventions under investigation include: DDI Test Report (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03581994?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.